Page last updated: 2024-09-02

schizandrin b and dinoprostone

schizandrin b has been researched along with dinoprostone in 2 studies

Compound Research Comparison

Studies (schizandrin b)	Trials (schizandrin b)	Recent Studies (post-2010) (schizandrin b)	Studies (dinoprostone)	Trials (dinoprostone)	Recent Studies (post-2010) (dinoprostone)
321	1	218	29,105	1,346	6,357
9	0	7	29,105	1,346	6,357

Protein Interaction Comparison

Protein	Taxonomy	dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtype	Homo sapiens (human)	0.0155
Prostaglandin E2 receptor EP4 subtype	Homo sapiens (human)	0.0031
Prostaglandin E2 receptor EP4 subtype	Rattus norvegicus (Norway rat)	0.0021
Prostaglandin E2 receptor EP3 subtype	Homo sapiens (human)	0.002
Prostaglandin E2 receptor EP2 subtype	Homo sapiens (human)	0.0087
Prostacyclin receptor	Homo sapiens (human)	0.26
Prostaglandin E2 receptor EP2 subtype	Rattus norvegicus (Norway rat)	0.0052

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, H; Liu, GX; Wang, XM; Zeng, KW; Zhang, T	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1

Other Studies

2 other study(ies) available for schizandrin b and dinoprostone

Article	Year
Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia. European journal of pharmacology, 2012, Oct-05, Volume: 692, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Coculture Techniques; Cyclooctanes; Dinoprostone; Down-Regulation; Enzyme Activation; I-kappa B Kinase; Interleukin-1beta; Interleukin-6; Lignans; Lipopolysaccharides; Male; Mice; Microglia; Myeloid Differentiation Factor 88; NADPH Oxidases; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2012
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012

Article

Year

Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia.

European journal of pharmacology, 2012, Oct-05, Volume: 692, Issue:1-3

Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Coculture Techniques; Cyclooctanes; Dinoprostone; Down-Regulation; Enzyme Activation; I-kappa B Kinase; Interleukin-1beta; Interleukin-6; Lignans; Lipopolysaccharides; Male; Mice; Microglia; Myeloid Differentiation Factor 88; NADPH Oxidases; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2012

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012